Comparative cardiovascular effects of GLP-1 agonists using real-world data.
Wallia A, O'Brien M, Hakimian S, Kang R, Cooper A, Lancki N, Stephen JJ, Aikman C, Liss D, Parker E, Ackermann RT.
Wallia A, et al.
Endocrinol Diabetes Metab. 2023 May;6(3):e339. doi: 10.1002/edm2.339. Epub 2023 Feb 24.
Endocrinol Diabetes Metab. 2023.
PMID: 36825925
Free PMC article.